Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome.
about
Sleep Duration, Exercise, Shift Work and Polycystic Ovarian Syndrome-Related Outcomes in a Healthy Population: A Cross-Sectional StudyHemodynamic Correlates of Abnormal Aortic Root Dimension in an Adult Population: The Strong Heart StudyThe metabolic syndromeImpaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice.Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycleIncreased Serum PAI-1 Levels in Subjects with Metabolic Syndrome and Long-Term Adverse Mental Symptoms: A Population-Based StudyThrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance.The genetics of obesity and the metabolic syndrome.Thrombospondin1 deficiency reduces obesity-associated inflammation and improves insulin sensitivity in a diet-induced obese mouse model.Metabolic effects of obesity: A reviewThe Association of the Metabolic Syndrome with PAI-1 and t-PA LevelsConsuming a balanced high fat diet for 16 weeks improves body composition, inflammation and vascular function parameters in obese premenopausal womenVascular biology of metabolic syndromeCardiometabolic risk among African American women: a pilot study.Different modulation by dietary restriction of adipokine expression in white adipose tissue sites in the rat.Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome.Histone H3 phosphorylation (Ser10, Ser28) and phosphoacetylation (K9S10) are differentially associated with gene expression in liver of rats treated in vivo with acute ethanolThe Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction.Sleep-disordered breathing in overweight and obese children and adolescents: prevalence, characteristics and the role of fat distributionThe inflammation highway: metabolism accelerates inflammatory traffic in obesity.Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study.Molecular determinants of the adrenal gland functioning related to stress-sensitive hypertension in ISIAH rats.Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?Serpins in thrombosis, hemostasis and fibrinolysisAdipocytokines and the metabolic complications of obesity.Once fat was fat and that was that: our changing perspectives on adipose tissue.Simvastatin reduces circulating plasminogen activator inhibitor 1 activity in volunteers with the metabolic syndromePlasminogen Activator Inhibitor-1 and Diagnosis of the Metabolic Syndrome in a West African Population.Genome-wide hepatic DNA methylation changes in high-fat diet-induced obese mice.Inflammatory mediators involved in the progression of the metabolic syndrome.Biology of metabolic syndrome in a vascular patient.Plasminogen activator inhibitor-1 inhibitors: a patent review (2006-present).Thrombin promotes diet-induced obesity through fibrin-driven inflammation.A novel plasminogen activator inhibitor-1 inhibitor, TM5441, protects against high-fat diet-induced obesity and adipocyte injury in mice.The levels of the adipokines adipsin and leptin are associated with knee osteoarthritis progression as assessed by MRI and incidence of total knee replacement in symptomatic osteoarthritis patients: a post hoc analysis.Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese.Vascular biomarkers in the metabolic syndrome.The study of markers of endothelial dysfunction in metabolic syndrome.Insulin resistance is associated with at least threefold increased risk for prothrombotic state in severely obese youngsters.Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome.
P2860
Q28917062-D564C104-9AB8-4BBE-9F96-6C23567DEC40Q30385080-3FB517CC-80CA-456C-8967-5C36A74726ADQ33569142-C0A2CF2A-2354-495F-8A99-7664E2F3D544Q33655519-AA996D35-5686-4601-A9AB-67ACB8FB58EAQ33715393-17B21D45-21A9-47FD-ADB2-72BCF3845A1BQ33726132-C3902CE5-EE00-4FE1-AE43-327037425F29Q33882773-8AFA0223-A7D6-46AE-B2BD-F4093BD5B21BQ33886816-01303A4A-433A-43FF-8604-CC158CF2EA52Q34062545-8DCE825D-CD43-4FBC-BEE7-F134386E4EA4Q34877856-3B9551EE-950B-4A24-8561-77159ACDEFAEQ34929646-569C9E51-BF45-4162-BB7C-137704A5664FQ35012734-0B08699B-F153-4A4E-9F73-E5CFD4CC9D61Q35106315-1ECA6B3F-9767-4C27-B743-0F6CEBC783CAQ35485393-29A4FD54-EDA1-46B0-8FFD-511E812E7E43Q35574740-71678E9B-CCC2-4F2E-B487-C6CC9B90E365Q35686289-0BE6F7EE-8A4A-4488-9DFD-34FCA145281BQ35688536-1AF1467D-E7A3-42CC-B17A-C40B8406F836Q35931125-F9D90A6F-A040-4C47-B051-057F11C8719AQ36154481-40427466-92AB-42B5-AB2E-3D6B88E12BC5Q36174974-F68845DD-5290-466F-9FB2-1BDD5D2B3B0FQ36249248-B9B6903F-338F-493E-BC37-B024860F4F93Q36254992-75341AC9-51D5-449D-926F-066C8C198913Q36478676-8A8FE647-23DE-4146-9737-C8D1CD84B767Q36884340-8F373FA2-5D42-4BC2-8192-C72706D148C5Q36979754-6E1BD026-AD35-4D6F-86F8-6C891247742AQ37041935-8BBC1900-C63D-4141-BF38-90DA65BD295BQ37218397-62921FAC-303A-4C21-92DB-E1BB943BBCECQ37434624-D1D24465-959F-4724-827C-9D6A93F0A7ECQ37733662-4DBDED97-C380-4030-B495-B97288F58045Q37990459-82D154DE-D12E-476D-97DF-936F0C76627CQ38018900-3EDE6189-BE2A-43C5-B643-AFA743EDEE42Q38092174-5C01A7B5-EB5B-4400-8A26-D5CFBF4157ECQ38665177-5E1D6059-1C97-48A4-9819-06288D317C3AQ39658243-207FEA20-4341-4747-A2F7-6445DD53344AQ40218511-55E7EE3D-0A88-4DE8-A1AD-043E5B998425Q43146865-E3C6CEF5-A709-43E7-8F1B-8B73BC3E6D4AQ46044501-1F090C3F-4F34-4718-9B85-105FC6678B8EQ48924965-785F96A5-9305-4740-BE22-2CC0C057F1AFQ51384972-0D7F5F8D-0C40-4160-9F94-C820386881B9Q51473862-F5A747BA-20DB-43B8-80EC-6CB174F8D7E8
P2860
Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Among inflammation and coagula ...... ent of the metabolic syndrome.
@en
Among inflammation and coagula ...... ent of the metabolic syndrome.
@nl
type
label
Among inflammation and coagula ...... ent of the metabolic syndrome.
@en
Among inflammation and coagula ...... ent of the metabolic syndrome.
@nl
prefLabel
Among inflammation and coagula ...... ent of the metabolic syndrome.
@en
Among inflammation and coagula ...... ent of the metabolic syndrome.
@nl
P2093
P356
P1476
Among inflammation and coagula ...... ent of the metabolic syndrome.
@en
P2093
A Verrijken
J J Michiels
L F Van Gaal
M Van der Planken
P2888
P304
P356
10.1038/SJ.IJO.0803189
P407
P577
2006-01-03T00:00:00Z